In BRAF-mutant cell lines, the activation of Wnt/β-catenin signaling in combination with BRAFi synergistically enhanced apoptosis in vitro and increased inhibition of tumor growth in vivo[27]. The gene discussed is BRAF; the disease is neoplasm.